Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations · Regulation FD disclosure
  4. 4 Grant or award Director acquired 644 shares (grant or award)
  5. 4 Grant or award Director acquired 1,288 shares (grant or award)
  6. 4 Grant or award Director acquired 1,159 shares (grant or award)
  7. 4 Grant or award Director acquired 644 shares (grant or award)
  8. 4 Grant or award Director acquired 1,288 shares (grant or award)
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations · Regulation FD disclosure
  14. 8-K/A Event Exit or restructuring costs
  15. 8-K Event Exit or restructuring costs · Regulation FD disclosure
  16. 4 Grant or award Director acquired 15,294 shares (grant or award)
  17. 4 Grant or award Director acquired 15,294 shares (grant or award)
  18. 4 Grant or award Director acquired 15,294 shares (grant or award)
  19. 4 Grant or award Director acquired 15,294 shares (grant or award)
  20. 4 Grant or award Director acquired 15,294 shares (grant or award)

Page 1 of 99 · 1,967 filings